Report Scope & Overview:
Active Ingredients Market Size was valued at USD 235.48 billion in 2022, and expected to reach USD 383.86 billion by 2030, and grow at a CAGR of 6.3% over the forecast period 2023-2030.
Technological developments are critical because improvements in manufacturing methods and analytical techniques improve the efficiency and quality of active ingredient production. Furthermore, the growing global population and improved healthcare awareness drive up demand for pharmaceuticals and personal care goods, which drives up demand for active ingredients. Regulatory changes and quality standards have an impact on the market as well, as severe requirements force manufacturers to enhance formulations and follow safety criteria, the growing popularity of natural and organic products has increased demand for plant-based and naturally derived active substances. the biopharmaceutical sector is booming, as is research into innovative medicines.
Get More Information on Active Ingredients Market - Request Sample Report
The Active Ingredients Market has to deal with a significant restraints that may have an impact on its growth and activities. Stringent regulatory clearances and compliance criteria can create entry hurdles for new players, making it difficult to introduce new active ingredients to the market. Furthermore, the high expenditures of research and development, along with the complexity of manufacturing processes, might limit innovation and impede market expansion. Disruptions in the supply chain, such as raw material shortages or conflicts, can lead to insecurity in the availability of active ingredients, reducing manufacturers' capacity to meet demand.
Market Dynamics:
Drivers:
Increasing demand for sun protection, skin whitening, and anti-aging products
Extensive use in the production of drugs
The extensive utilization of certain ingredients in pharmaceutical drug production signifies a compelling market driver. This prevalence of use underscores the consistent demand for these active ingredients within the pharmaceutical sector. It reflects the industry's need for reliable and essential components, which, in turn, contributes to the sustained growth and relevance of these ingredients within the market.
Restraints:
Regulatory limitations
consumer preferences and demand for natural or sustainable ingredients
Manufacturers to align their product offerings with changing consumer preferences, particularly towards natural or sustainable ingredients. This requires significant adjustments in formulation, sourcing, and production processes, which can be challenging and resource-intensive. Manufacturers must invest in research, development, and sustainability initiatives to meet these evolving demands while ensuring product efficacy and compliance with regulatory standards. This can strain resources and necessitate strategic planning to successfully adapt to shifting consumer preferences.
Challenge:
High Manufacturing Cost
Market Competition
In the Active Ingredients Market, fierce competition among manufacturers often results in price wars as companies vie for market share. These price battles can erode profit margins for all players involved, making it challenging to maintain profitability. To thrive in this competitive landscape, companies must focus on differentiation, innovation, and cost-efficiency strategies.
Opportunity:
Growing Demand for Ingredients with Multiple Uses
Environmentally hazardous chemicals in personal care products are a worry
Multiple uses lie in the potential for market expansion and increased revenue streams. Manufacturers can create versatile ingredients that cater to a wide range of applications across industries, such as pharmaceuticals, cosmetics, and food. This diversification can lead to reduced reliance on a single market segment, lower risk exposure, and the ability to tap into new customer bases. By developing multifunctional ingredients, companies can position themselves to meet evolving market demands and enhance their competitive advantage.
Impact of COVID-19:
The COVID-19 pandemic had a positive effect on the market for active pharmaceutical components since the big producers produced enormous quantities of chemicals to meet the demand for COVID-19 treatment. The many COVID-19 strains and cases of black fungus have led to the development of a number of medications. Drug companies have changed their business strategies in response to the COVID-19 epidemic to concentrate on a bigger patient base. For instance, India's output of hydroxychloroquine surged as a result of the US's request to import it as a therapy for COVID-19. Additionally, the global research and development for the COVID-19 vaccine increased the demand for a variety of active components.
IMPACT OF RUSSIA UKRAINE WAR
Russia's involvement in a war would have a major and several impact on the active ingredient market. Because Russia is a key worldwide player in a variety of industries, including pharmaceuticals and chemicals, Ukraine and Russia produce 80% of all screening chemicals used in medication research and development. Any war might disrupt supply chains and trading routes for active substances used in the production of medications and products all over the world. Before the war, chemical items accounted for 9% of all industrial exports from Ukraine.
This disruption would almost certainly result in shortages, higher pricing, and probable quality issues in the pharmaceutical and consumer goods sectors. Furthermore, geopolitical tensions and uncertainty may prevent investments and cooperation, further straining the active ingredient market's stability.
IMPACT OF RECESSION
The impact of the recession on the Active Ingredients Market would be significant and negative. Economic downturns often result in lower consumer spending and demand for a variety of products, including pharmaceuticals and consumer goods. Following an excellent 2022 in which chemical production increased by 3.9%, predicts that output will fall by 1.2% in 2023. This would almost certainly result in a decline in active ingredient production and sales, impacting manufacturers' revenues and profitability. Furthermore, corporations may reduce their investments in research and development, thereby impeding market innovation. Overall, a recession would create a difficult environment for the Active Ingredients Market, with weaker demand, supply chain disruptions, and probable shifts in industry dynamics.
Market Segment:
By End Use
Personal Care & Cosmetics
Pharmaceuticals
Regional Analysis:
North America: North America dominating market by highest share, the market in North America is primarily driven by the rising prevalence of chronic diseases that are preventable, the government's increased emphasis on generic medications, the need for biologics and speciality medications, and improvements in API production technology.
Europe: Due to the expansion of the personal care and cosmetics sectors in the continent, there will likely be a significant demand for active ingredients in the European market.
Asia-Pacific: Due to the region's quick industrialization, Asia-Pacific has the fastest-growing regional market. Emerging economies like India, South Korea, Thailand, and Malaysia have the greatest growth potential. Due to the presence of agricultural countries in the region and the rising demand for agrochemicals, the Asia-Pacific active ingredients market has been consistently expanding.
REGIONAL COVERAGE
North America
US
Canada
Mexico
Europe
Eastern Europe
Poland
Romania
Hungary
Turkey
Rest of Eastern Europe
Western Europe
Germany
France
UK
Italy
Spain
Netherlands
Switzerland
Austria
Rest of Western Europe
Asia Pacific
China
India
Japan
South Korea
Vietnam
Singapore
Australia
Rest of Asia Pacific
Middle East & Africa
Middle East
UAE
Egypt
Saudi Arabia
Qatar
Rest of Middle East
Africa
Nigeria
South Africa
Rest of Africa
Latin America
Brazil
Argentina
Colombia
Rest of Latin America
Key Players:
AkzoNobel N.V. (The Netherlands), Evonik Industries AG (Germany), Ashland (US), Clariant (Switzerland), BASF SE (Germany), Lonza (Switzerland), DuPont (US), Sumitomo Corp (Japan), FMC Corporation (US), Croda International Plc(UK), Eastman Chemical Company (US), and other players.
Evonik Industries AG (Germany)-Company Financial Analysis
Get Customized Report as per your Business Requirement - Request For Customized Report
RECENT DEVELOPMENTS
In February 2023, Givaudan, the worldwide leader in fragrance and beauty innovation, unveiled its strategic vision for 2025, focused on delivering innovative and enhanced products to grow its Active Beauty division.
In July 2023, Teva Pharmaceuticals is contemplating the sale of its $2 billion active pharmaceutical ingredients (API) unit as part of its "Pivot to Growth" strategy.
| Report Attributes | Details |
|---|---|
| Market Size in 2022 | US$ 235.48 Billion |
| Market Size by 2030 | US$ 383.36 Billion |
| CAGR | CAGR of 6.3% From 2023 to 2030 |
| Base Year | 2022 |
| Forecast Period | 2023-2030 |
| Historical Data | 2019-2021 |
| Report Scope & Coverage | Market Size, Segments Analysis, Competitive Landscape, Regional Analysis, DROC & SWOT Analysis, Forecast Outlook |
| Key Segments | • By End Use (Personal Care & Cosmetics, Pharmaceuticals, Agrochemicals) |
| Regional Analysis/Coverage | North America (US, Canada, Mexico), Europe (Eastern Europe [Poland, Romania, Hungary, Turkey, Rest of Eastern Europe] Western Europe] Germany, France, UK, Italy, Spain, Netherlands, Switzerland, Austria, Rest of Western Europe]), Asia Pacific (China, India, Japan, South Korea, Vietnam, Singapore, Australia, Rest of Asia Pacific), Middle East & Africa (Middle East [UAE, Egypt, Saudi Arabia, Qatar, Rest of Middle East], Africa [Nigeria, South Africa, Rest of Africa], Latin America (Brazil, Argentina, Colombia Rest of Latin America) |
| Company Profiles | AkzoNobel N.V. (The Netherlands), Evonik Industries AG (Germany), Ashland (US), Clariant (Switzerland), BASF SE (Germany), Lonza (Switzerland), DuPont (US), Sumitomo Corp (Japan), FMC Corporation (US), Croda International Plc(UK), Eastman Chemical Company (US), and other players. |
| DRIVERS | • Increasing demand for sun protection, skin whitening, and anti-aging products. • Extensive use in the production of drugs. |
| Restraints | • Regulatory limitations. • consumer preferences and demand for natural or sustainable ingredients |
Ans: Personal Care & Cosmetics, Pharmaceuticals and Agrochemicals are the sub-segments of by end user segment.
Ans: Manufacturers, Consultant, aftermarket players, association, Research institute, private and universities libraries, suppliers and distributors of the product.
Ans: Regulatory limitations are the restraints for Active Ingredients Market.
Ans: AkzoNobel N.V. (The Netherlands), Evonik Industries AG (Germany), Ashland (US), Clariant (Switzerland), BASF SE (Germany), Lonza (Switzerland), DuPont (US), Sumitomo Corp (Japan), FMC Corporation (US), Croda International Plc(UK), Eastman Chemical Company (US) are the major key players of Active Ingredients Market.
Ans: Active Ingredients Market Size was valued at USD 221.5 billion in 2021, and expected to reach USD 339.7 billion by 2028, and grow at a CAGR of 6.3% over the forecast period 2022-2028.
Table of Contents
1. Introduction
1.1 Market Definition
1.2 Scope
1.3 Research Assumptions
2. Research Methodology
3. Market Dynamics
3.1 Drivers
3.2 Restraints
3.3 Opportunities
3.4 Challenges
4. Impact Analysis
4.1 Impact of Ukraine- Russia War
4.2 Impact of Ongoing Recession
4.3. Introduction
4.3.1 Impact on major economies
4.3.1.1 US
4.3.1.2 Canada
4.3.1.3 Germany
4.3.1.4 France
4.3.1.5 United Kingdom
4.3.1.6 China
4.3.1.7 Japan
4.3.1.8 South Korea
4.3.1.9 Rest of the World
5. Value Chain Analysis
6. Porter’s 5 forces model
7. PEST Analysis
8. Active Ingredients Market Segmentation, By End Use
8.1 Personal Care & Cosmetics
8.2 Pharmaceuticals
8.3 Agrochemicals
9. Regional Analysis
9.1 Introduction
9.2 North America
9.2.1 North America Active Ingredients Market by Country
9.2.2 North America Active Ingredients Market by End Use
9.2.4 USA
9.2.4.1 USA Active Ingredients Market by End Use
9.2.5 Canada
9.2.5.1 Canada Active Ingredients Market by End Use
9.2.6 Mexico
9.2.6.1 Mexico Active Ingredients Market by End Use
9.3 Europe
9.3.1 Eastern Europe
9.3.1.1 Eastern Europe Active Ingredients Market by Country
9.3.1.2 Eastern Europe Active Ingredients Market by Cheat
9.3.1.4 Poland
9.3.1.4.1 Poland Active Ingredients Market by End Use
9.3.1.5 Romania
10.3.1.5.1 Romania Active Ingredients Market by End Use
9.3.1.6 Hungary
9.3.1.6.1 Hungary Active Ingredients Market by End Use
9.3.1.7 Turkey
9.3.1.7.1 Turkey Active Ingredients Market by End Use
9.3.1.8 Rest of Eastern Europe
9.3.1.8.1 Rest of Eastern Europe Active Ingredients Market by End Use
9.3.2 Western Europe
9.3.2.1 Western Europe Active Ingredients Market by Country
9.3.2.2 Western Europe Active Ingredients Market by End Use
9.3.2.4 Germany
9.3.2.4.1 Germany Active Ingredients Market by End Use
9.3.2.5 France
9.3.2.5.1 France Active Ingredients Market by End Use
9.3.2.6 UK
9.3.2.6.1 UK Active Ingredients Market by End Use
9.3.2.7 Italy
9.3.2.7.1 Italy Active Ingredients Market by End Use
9.3.2.8 Spain
9.3.2.8.1 Spain Active Ingredients Market by End Use
9.3.2.9 Netherlands
9.3.2.9.1 Netherlands Active Ingredients Market by End Use
9.3.2.10.1 Switzerland Active Ingredients Market by End Use
9.3.2.11 Austria
9.3.2.11.1 Austria Active Ingredients Market by End Use
9.3.2.12 Rest of Western Europe
9.3.2.12.1 Rest of Western Europe Active Ingredients Market by End Use
9.4.1 Asia Pacific Active Ingredients Market by Country
10.4.2 Asia Pacific Active Ingredients Market by End Use
9.4.4 China
9.4.4.1 China Active Ingredients Market by End Use
9.4.5 India
9.4.5.1 India Active Ingredients Market by End Use
9.4.6 Japan
9.4.6.1 Japan Active Ingredients Market by End Use
9.4.7 South Korea
9.4.7.1 South Korea Active Ingredients Market by End Use
9.4.8 Vietnam
9.4.8.1 Vietnam Active Ingredients Market by End Use
9.4.9 Singapore
9.4.9.1 Singapore Active Ingredients Market by End Use
9.4.10 Australia
9.4.10.1 Australia Active Ingredients Market by End Use
9.4.11 Rest of Asia-Pacific
9.4.11.1 Rest of Asia-Pacific Active Ingredients Market by End Use
9.5 Middle East & Africa
9.5.1 Middle East
9.5.1.1 Middle East Active Ingredients Market by Country
9.5.1.2 Middle East Active Ingredients Market by End Use
9.5.1.4 UAE
9.5.1.4.1 UAE Active Ingredients Market by End Use
9.5.1.5 Egypt
9.5.1.5.1 Egypt Active Ingredients Market by End Use
9.5.1.6 Saudi Arabia
9.5.1.6.1 Saudi Arabia Active Ingredients Market by End Use
9.5.1.7 Qatar
9.5.1.7.1 Qatar Active Ingredients Market by End Use
9.5.1.8 Rest of Middle East
9.5.1.8.1 Rest of Middle East Active Ingredients Market by End Use
9.5.2 Africa
9.5.2.1 Africa Active Ingredients Market by Country
9.5.2.2 Africa Active Ingredients Market by End Use
9.5.2.4 Nigeria
9.5.2.4.1 Nigeria Active Ingredients Market by End Use
9.5.2.5 South Africa
9.5.2.5.1 South Africa Active Ingredients Market by End Use
9.5.2.6 Rest of Africa
9.5.2.6.1 Rest of Africa Active Ingredients Market by End Use
9.6 Latin America
9.6.1 Latin America Active Ingredients Market by Country
9.6.4 Brazil
9.6.4.1 Brazil Active Ingredients Market by End Use
9.6.5 Argentina
9.6.5.1 Argentina Active Ingredients Market by End Use
9.6.6 Colombia
9.6.6.1 Colombia Active Ingredients Market by End Use
9.6.7 Rest of Latin America
9.6.7.1 Rest of Latin America Active Ingredients Market by End Use
10 Company Profile
10.1 AkzoNobel N.V.
10.1.1 Company Overview
10.1.2 Financials
10.1.3 Product/Services Offered
10.1.4 SWOT Analysis
10.1.5 The SNS View
10.2 Evonik Industries AG
10.2.1 Company Overview
10.2.2 Financials
10.2.3 Product/Services Offered
10.2.4 SWOT Analysis
10.2.5 The SNS View
10.3 Ashland
10.3.1 Company Overview
10.3.2 Financials
10.3.3 Product/Services Offered
10.3.4 SWOT Analysis
10.3.5 The SNS View
10.4 Clariant
10.4 Company Overview
10.4.2 Financials
10.4.3 Product/Services Offered
10.4.4 SWOT Analysis
10.4.5 The SNS View
10.5 BASF SE
10.5.1 Company Overview
10.5.2 Financials
10.5.3 Product/Services Offered
10.5.4 SWOT Analysis
10.5.5 The SNS View
10.6 Lonza
10.6.1 Company Overview
10.6.2 Financials
10.6.3 Product/Services Offered
10.6.4 SWOT Analysis
10.6.5 The SNS View
10.7 DuPont
10.7.1 Company Overview
10.7.2 Financials
10.7.3 Product/Services Offered
10.7.4 SWOT Analysis
10.7.5 The SNS View
10.8 Sumitomo Corp
10.8.1 Company Overview
10.8.2 Financials
10.8.3 Product/Services Offered
10.8.4 SWOT Analysis
10.8.5 The SNS View
10.9 FMC Corporation
10.9.1 Company Overview
10.9.2 Financials
10.9.3 Product/ Services Offered
10.9.4 SWOT Analysis
10.9.5 The SNS View
10.10 Croda International Plc
10.10.1 Company Overview
10.10.2 Financials
10.10.3 Product/Services Offered
10.10.4 SWOT Analysis
10.10.5 The SNS View
10.11 Eastman Chemical Company
10.11.1 Company Overview
10.11.2 Financials
10.11.3 Product/Services Offered
10.11.4 SWOT Analysis
10.11.5 The SNS View
11. Competitive Landscape
11.1 Competitive Bench marking
11.2 Market Share Analysis
11.3 Recent Developments
11.3.1 Industry News
11.3.2 Company News
11.3.3 Mergers & Acquisitions
12. USE Cases and Best Practices
13. Conclusion
An accurate research report requires proper strategizing as well as implementation. There are multiple factors involved in the completion of good and accurate research report and selecting the best methodology to compete the research is the toughest part. Since the research reports we provide play a crucial role in any company’s decision-making process, therefore we at SNS Insider always believe that we should choose the best method which gives us results closer to reality. This allows us to reach at a stage wherein we can provide our clients best and accurate investment to output ratio.
Each report that we prepare takes a timeframe of 350-400 business hours for production. Starting from the selection of titles through a couple of in-depth brain storming session to the final QC process before uploading our titles on our website we dedicate around 350 working hours. The titles are selected based on their current market cap and the foreseen CAGR and growth.
The 5 steps process:
Step 1: Secondary Research:
Secondary Research or Desk Research is as the name suggests is a research process wherein, we collect data through the readily available information. In this process we use various paid and unpaid databases which our team has access to and gather data through the same. This includes examining of listed companies’ annual reports, Journals, SEC filling etc. Apart from this our team has access to various associations across the globe across different industries. Lastly, we have exchange relationships with various university as well as individual libraries.
Step 2: Primary Research
When we talk about primary research, it is a type of study in which the researchers collect relevant data samples directly, rather than relying on previously collected data. This type of research is focused on gaining content specific facts that can be sued to solve specific problems. Since the collected data is fresh and first hand therefore it makes the study more accurate and genuine.
We at SNS Insider have divided Primary Research into 2 parts.
Part 1 wherein we interview the KOLs of major players as well as the upcoming ones across various geographic regions. This allows us to have their view over the market scenario and acts as an important tool to come closer to the accurate market numbers. As many as 45 paid and unpaid primary interviews are taken from both the demand and supply side of the industry to make sure we land at an accurate judgement and analysis of the market.
This step involves the triangulation of data wherein our team analyses the interview transcripts, online survey responses and observation of on filed participants. The below mentioned chart should give a better understanding of the part 1 of the primary interview.
Part 2: In this part of primary research the data collected via secondary research and the part 1 of the primary research is validated with the interviews from individual consultants and subject matter experts.
Consultants are those set of people who have at least 12 years of experience and expertise within the industry whereas Subject Matter Experts are those with at least 15 years of experience behind their back within the same space. The data with the help of two main processes i.e., FGDs (Focused Group Discussions) and IDs (Individual Discussions). This gives us a 3rd party nonbiased primary view of the market scenario making it a more dependable one while collation of the data pointers.
Step 3: Data Bank Validation
Once all the information is collected via primary and secondary sources, we run that information for data validation. At our intelligence centre our research heads track a lot of information related to the market which includes the quarterly reports, the daily stock prices, and other relevant information. Our data bank server gets updated every fortnight and that is how the information which we collected using our primary and secondary information is revalidated in real time.
Step 4: QA/QC Process
After all the data collection and validation our team does a final level of quality check and quality assurance to get rid of any unwanted or undesired mistakes. This might include but not limited to getting rid of the any typos, duplication of numbers or missing of any important information. The people involved in this process include technical content writers, research heads and graphics people. Once this process is completed the title gets uploader on our platform for our clients to read it.
Step 5: Final QC/QA Process:
This is the last process and comes when the client has ordered the study. In this process a final QA/QC is done before the study is emailed to the client. Since we believe in giving our clients a good experience of our research studies, therefore, to make sure that we do not lack at our end in any way humanly possible we do a final round of quality check and then dispatch the study to the client.
The Battery Metals Market Size was valued at expected to reach USD 23.94 billion by 2030, and USD 18.18 billion in 2022 and grow at a CAGR of 3.5 % over the forecast period 2023-2030.
The Unsaturated Polyester Resins Market Size was valued at USD 10.31 billion in 2022, and is expected to reach USD 16.81 billion by 2030, and grow at a CAGR of 6.3% over the forecast period 2023-2030.
Medical Textiles Market Size was valued at USD 26.80 billion by the end of 2022 and is projected to reach USD 37.53 billion by 2030, with a growing healthy CAGR of 4.3% during the forecast period 2023-2030.
The Construction Sealants Market is assessed to be USD 9.09 billion by 2022, at a CAGR of 5.8% during the figure time frame. The base year considered for this study is 2022 and the gauge period is from 2022 to 2028 assessed to reach 14.28 billion by 2030.
The Unidirectional Tapes Market Size was valued at USD 241.18 Million in 2022, and expected to reach USD 576.16 million by 2030, and grow at a CAGR of 11.5% over the forecast period 2023-2030.
The Integrated Pest Management Pheromones Market size was valued at USD 912.25 million in 2022 and is expected to grow to USD 1676.04 million by 2030 and grow at a CAGR of 7.9% over the forecast period of 2023-2030.
Hi! Click one of our member below to chat on Phone
© 2023 All Rights Reserved by SNS Insider Pvt Ltd
